Meanwhile, there was also a significant correlation between the high level of ANRIL expression and the OS of patients with cancer with a follow-up time equal to or <5 years (HR = 1.75, 95% CI: 1.52–2.01, P < .0001) and >5 years (HR = 1.87, 95% CI: 1.44–2.42, P < .0001). The gene discussed is CDKN2B-AS1; the disease is cancer.